Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 05, 2007 | Ten Percent Owner | Conversion of derivative security | Form 4 | 2,904 | -- | -- | |
| Jun 05, 2007 | Director, Ten Percent Owner | Conversion of derivative security | Form 4 | 2,904 | -- | -- | |
| Jul 26, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,925 | $11.50 | 205,015 | |
| Jul 26, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 2,925 | $11.50 | 205,015 | |
| Jun 16, 2020 | Principal Accounting Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 2,932 | $12.95 | 17,135 | |
| Jul 14, 2023 | Chief Accounting Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | 2,940 | -- | -- | |
| Sep 03, 2021 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,945 | $9.55 | 88,095 | |
| Sep 03, 2021 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 2,945 | -- | 12,182 | |
| Jan 03, 2018 | SVP, Finance | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 2,953 | $15.67 | 64,332 | |
| Aug 23, 2017 | Chief Medical Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 3,000 | -- | 3,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.